Clinical Trials Week
Susan Hasty, Publisher
Table of Contents . . . September 5th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Clinical Trials Week | Other Publications
Arthritis - Arthritis examined, serum cartilage oligomeric matrix protein clarified
Embolism - Clinical outcome of patients with venous thromboembolism revealed
Hypertension Therapy - Results of STRATHE study released
Pediatric Cancer Therapy - Micafungin pharmacokinetics during febrile neutropenia determined
Seasonal Allergic Rhinitis - Levocetirizine controls symptoms for entire pollen season
Acid Reflux - Esomeprazole and lansoprazole gastric acid suppression compared
Allergies - Enrolment in phase II clinical trial of R112 for allergies initiated
Allergy Medicine - Extracts from Butterbur are an effective nondrowsy treatment for "hay fever"
Alzheimer Disease - Phase 1 clinical trial of treatment for Alzheimer disease initiated
Amyotrophic Lateral Sclerosis - Company receives correspondence from FDA concerning phase II arimoclomol study
Angiology - New data illuminates research in angiology
Asthma - Asthma attack analyzed, bronchial exudate of serum proteins clarified
Awards - Macugen pegaptanib sodium injection named Innovative Pharmaceutical Product 2005
Bacterial Vaginosis - To understand BV, more research is needed on vaginal flora, related issues
Bacteriology - U.S. FDA approves levofloxacin tablets to treat acute bacterial sinusitis
Benign Prostatic Hyperplasia - Phase 3 trial initiated in Europe for treatment of benign prostatic hyperplasia
Bladder Cancer - Company gets U.S. FDA clearance to initiate Chemophase clinical trial
Breast Cancer - Older women fare favorably with conservative breast cancer treatment
Breast Cancer - Postoperative loco-regional radiation therapy treated breast cancer
Breast Cancer - Recent findings in breast cancer provide new insights
Business & Finance - Biopharma company announces second quarter 2005 results
Business & Finance - Biopharma company reports Q2 2005 financial results, clinical trial outcomes
Business & Finance - Corlux maker announces second quarter net loss of $4.1 million
Business & Finance - Gene-transfer company reports Q2 financial results, updates GENASIS trial
Business & Finance - NeuroPort developer announces second quarter net loss of $2,414,000
Business & Finance - Pharmaceutical company reports second quarter 2005 financial results
Business & Finance - Therapeutics development company gives financial results, corporate update
Business Update - Biopharmaceutical company announces restructuring of operations and finances
Business Update - Company announces amended agreement with Merck & Co. regarding antidepressants
Business Update - European biopharma awards $1.9M for cardiac safety monitoring and services
Cancer Therapy - Research add new data to cancer therapy body of knowledge
Cancer Therapy - Two additional sites initiated for phase II ADH-1 trial
Cancer Therapy - U.S. NIH awards grant for preclinical development of Talotrexin in combo therapy
Cancer Vaccine - Phase 1 study of TNF-alpha AutoVaccIne in metastatic cancer reported
Cardiac Arrest - Impedance threshold device improves blood pressure during CPR
Cardiology - First of two pivotal phase 3 studies of regadenoson met its primary endpoint
Cardiopulmonary Bypass - Plasma cortisol levels with maximal anti-inflammatory effects determined
Cardiovascular Research - Pathogenesis of vascular calcification in chronic kidney disease
Cervical Carcinoma - Differing regimens of neoadjuvant chemotherapy compared
Clinical Trials - Biopharma company and PharmAthene announce IND filing with U.S. FDA for Valortim
Clinical Trials - Clinical trials of SCT in multiple sclerosis are currently premature
Clinical Trials - EDC in clinical trials slow to catch on, company says; more training needed
Clinical Trials - Trial confirms effectiveness of nutrient on memory in aging animals
Clinical Trials - Trial design company announces East 4, EastSurv, and EastAdapt modules
Complementary & Alternative Medicine - Acupuncture may improve sperm quality
Depression Therapy - Estrogen augmentation of antidepressants in perimenopausal depression examined
Depression Treatments - Clinical trials reveal sex differences in antidepressant response
Dermatology - Effects of psoriasis treatment reported
Diabetes Therapy - Liraglutide improves glycemic control and body weight in diabetes
Diabetes Therapy - Pioglitazone better than metformin for improving insulin sensitivity
Diabetic Foot - Researchers decide to end feasibility study on diabetic foot ulcers
Diagnostics - Serum matrix metalloproteinase-9 may be a prognostic marker
Diet & Nutrition - Dietary fat intake and early mortality patterns in Malmo analyzed
Drug Development - Biotech company starts process for manufacture of ThromboView
Drug Development - Differences in biopharmaceutical information in E.U. and U.S. examined
Drug Development - Enrollment completed for phase III trial of pexelizumab
Drug Development - GMP materials pass QC release for phase I/II trial in cervical cancer
Drug Development - High throughput screening services company awarded phase II SBIR grant
Drug Development - Phase I trial initiated for Venezuelan equine encephalitis vaccine candidate
Drug Development - Study with bosentan shows reduction of new digital ulcers in sclerosis patients
Erythromycin - Effect of erythromycin might be due to inhibition of MMP-2 in VSMCs
Finance - ASP announces second-quarter operating results
Finance - Biopharma company reports financial results
Finance - Biopharmaceutical firm reports loss of $0.11 per share
Finance - Biotechnology company reports second quarter 2005 results
Finance - CNS-focused company announces second quarter 2005 results
Finance - California-based pharmaceutical company reports Q2, year-to-date 2005 results
Finance - Cancer-focused bioscience company announces 4,500,000-share stock offering
Finance - Carbohydrate compound developer reports second quarter results
Finance - Genomics-based drug-discovery company reports Q2 net loss of $9.7M
Finance - Pharma company announces financial results
Finance - Pharma company announces second quarter 2005 financial results
Finance - Pharma firm reports loss of $0.10 per share, anti-nausea drug trial update
Glioblastoma Vaccine - Dendritic cell vaccine in glioblastoma induces T-cell responses
HIV/AIDS Drug Side Effect - Efavirenz diminishes antilipid efficacy of HMG-CoA reductase inhibitors
Head & Neck Cancer - Increased mtDNA content in saliva associated with head and neck cancer
Heart Disease - Interest increases in interventions that improve health-related QoL
Hemophilia - Data for Advate confirm safety and efficacy in hemophilia A patients
Hepatitis B Virus - Company announces end of patient dosing in HepeX-B hepatitis B phase II trial
Hepatitis C Therapy - Health Canada approves study of celgosivir compound in HCV non-responders
Hepatitis C Virus - Tarvacin phase I hepatitis C virus trial initiated
Hepatocellular Carcinoma - Percutaneous ethanol injection is safe and effective as first-line option
Influenza - Pharmaceutical company receives grant to test influenza drug candidate
Information Technology - Three new clinical trials added to electronic data capture system powered by SAS
Kidney Cancer - Differing combination treatments for genito-urinary tract cancer compared
Kidney Disease - Phase III program for ferumoxytol modified in IV iron replacement therapy
Knee Osteoarthritis - Pulsed shortwave therapy lacks anti-inflammatory activity
Laryngeal Cancer - Exposure to polycyclic aromatic hydrocarbons linked to laryngeal cancer risk
Leukemia - AML patients with Down syndrome showed high cure rate with AML-BFM therapy
Leukemia - Studies add new findings to leukemia body of knowledge
Lung Cancer - Familial lung cancer risks in U.K. women studied
Lung Cancer - Phase 2 clinical trial of non-small cell lung cancer treatment initiated
Lung Cancer Therapy - U.S. FDA approval summary of pemetrexed for lung cancer therapy released
Market Analysis - 88% of pharma companies involve thought leaders by the end of phase II
Medical Devices - Medical device company acquires cervical nucleus-like replacement device
Medical Devices - Preclinical studies of anti-adhesion thermal gel in gynecologic surgery underway
Medical Devices - Study evaluates use of implantable pulse generator for heart failure
Melanoma - First melanoma patients complete treatment in phase I clinical trial of PV-10
Melanoma Vaccine - Fusion with IL-2 enhances immunogenicity of anti-idiotypic antibody
Melanoma Vaccine - Vaccine targets tumor microenvironment for treatment of melanoma
Mental Health - Breathing therapy tested for panic attacks
Multiple Sclerosis - Current trials in multiple sclerosis reviewed
Myocardial Infarction - Inspra reduces risk of early death in heart attack patients with LVSD
Neonatology - Early HFOV highly beneficial for preterm infants
Non-Hodgkin Lymphoma - Fludarabine-mitoxantrone compared with CHVP as treatment of elderly patients
Obesity Surgery - Laparoscopic Roux-en-Y versus mini-gastric bypass outcomes compared
Ovarian Cancer - Transvaginal biopsy reviewed for diagnosis of ovarian cancer
Pain Management - Phase III trial of bicifadine for pain following vaginal hysterectomy begins
Pancreatic Cancer - Biopharma company reports second quarter 2005 financial results
Peripheral Arterial Occlusion - Clinical trial data of chronic peripheral arterial occlusion treatment published
Peripheral Neuropathy - Company inks agreement for treatment of diabetic neuropathy with VEGF-2
Personnel - Data management solutions provider names vice president marketing
Pharmaceutical Research - Market research firm releases study on pharma spending
Pneumococcal Vaccines - Findings advance knowledge in pneumococcal vaccines research
Product Licensing - Bioscience company signs license agreement for small molecule oncology compounds
Product Licensing - Cancer drugs licensed from University of Arizona Foundation
Prostate Cancer - Expansion of phase II clinical trial of PI-88 for prostate cancer announced
Prostate Cancer - Sun exposure and VDR gene polymorphisms linked to risk of prostate cancer
Prostate Cancer Vaccine - Antibody to prostate-specific membrane antigen used for cancer therapy
Pulmonary Hypertension - European mutual recognition procedure for pulmonary hypertension treatment done
Quality of Life - Exercise barriers faced by colorectal cancer survivors
Rheumatoid Arthritis - Adalimumab plus methotrexate effective for long-standing rheumatoid arthritis
Rheumatoid Arthritis - Efficacy of Ayurvedic medicine in treatment evaluated
Statins - Pravastatin induces regression of focal coronary atherosclerosis
Statins - Pravastatin reduced rate of kidney function loss
Stents - Drug-eluting stent was associated with lower risk of restenosis
Thyroid Cancer - Feasibility of 1H MR spectroscopy for thyroid carcinoma examined
Thyroid Cancer - Incidence of thyroid cancer in the renal transplant population estimated
Venous Thromboembolism - Data from two phase II studies for Factor Xa inhibitor presented
Wuchereria Therapy - Efficacy of combined treatment of helminth infections examined
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
